Adherence to endocrine therapy and sexual dysfunction in patients older than 65 years with early estrogen receptor-positive breast cancer

被引:0
|
作者
Assad, D. X. [1 ]
Dos Santos, D. L. [2 ]
Resende, H. M. [3 ]
Cesar Moura, F. [4 ]
Oliveira, S. C. S. [5 ]
Shimada, A. K. [6 ]
Arakelian, R. [7 ]
Galvao, A. L. [8 ]
Wance, B. [9 ]
Guimaraes Castro, A. [10 ]
Andrade, M. C. F. M. D. [11 ]
Cardoso Rodrigues Beckedorff Bittencourt, Y. [12 ]
Magalhaes, M. C. F. [13 ]
de Padua Souza, C. [14 ]
Paiva, C. E. [15 ]
Signorini, P. [16 ]
Pereira, D. J. [17 ]
Rodrigues, A. N. [18 ]
Rosa, D. D. [19 ]
Barroso-Sousa, R. [20 ]
机构
[1] Complexo Hosp Bela Vista, Hosp Sirio Libanes, Med Oncol Dept, Sao Paulo, Brazil
[2] Hemolabor Banco Sangue, Med Oncol Dept, Oncol Hematol & Lab, Goiania, Go, Brazil
[3] Radiclin Ctr Oncol, Oncol, Volta Redonda, Brazil
[4] HBDF Hosp Base Dist Fed, Clin Oncol, Brasilia, DF, Brazil
[5] Liga Norte Riograndense Canc, Oncol Dept, Natal, RN, Brazil
[6] Complexo Hosp Bela Vista, Hosp Sirio Libanes, Oncol, Sao Paulo, Brazil
[7] IOSP Inst Oncol Santa Paula, Clin Oncol, Sao Paulo, Brazil
[8] UniCEUB Ctr Univ Brasilia, Med, Brasilia, DF, Brazil
[9] Dasa Oncol, Hosp Brasilia, Clin Oncol, Brasilia, DF, Brazil
[10] Hosp Sirio Libanes, Nutr, Sao Paulo, Brazil
[11] Liga Norte Riograndense Canc, Clin Oncol, Natal, RN, Brazil
[12] Hosp Sirio Libanes, Clin Oncol, Sao Paulo, Brazil
[13] IHOC Inst Hematol & Oncol Curitiba, Oncol Dept, Grp Oncoclin, Curitiba, Parana, Brazil
[14] Hosp Canc Barretos, Hosp Amor, Fundacao Pio 12, Oncol Dept, Barretos, Brazil
[15] Hosp Canc Barretos, Hosp Amor, Fundacao Pio 12, Clin Oncol Dept, Barretos, Brazil
[16] CINPAM Ctr Integrado Pesquisa Amazonia, Clin Oncol, Manaus, Amazonas, Brazil
[17] Oncocentro, Grp Oncoclin, Clin Oncol, Belo Horizonte, MG, Brazil
[18] Univ Fed Minas Gerais, Fac Med, Oncol Dept, Belo Horizonte, MG, Brazil
[19] Hosp Moinhos de Vento, Porto Alegre, RS, Brazil
[20] Dasa Oncol, Hosp Brasilia, Oncol Ctr, Brasilia, SP, Brazil
关键词
D O I
10.1016/j.annonc.2024.08.226
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
285P
引用
收藏
页码:S334 / S334
页数:1
相关论文
共 50 条
  • [41] Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in estrogen receptor-positive breast cancer
    Kim, Ji Sun
    Han, Wonshik
    You, Jee Man
    Shin, Hee-Chul
    Ahn, Soo Kyung
    Moon, Hyeong Gon
    Im, Seock-Ah
    Kim, Tae-You
    Cho, Nariya
    Moon, Woo Kyung
    Noh, Dong Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer
    Gayathri Nagaraj
    Cynthia Ma
    Breast Cancer Research and Treatment, 2015, 150 : 231 - 242
  • [43] Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer
    Nagaraj, Gayathri
    Ma, Cynthia
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 231 - 242
  • [44] Impact of adjuvant endocrine therapy in older patients with comorbidities and estrogen receptor-positive, node-negative breast cancer-a National Cancer Database analysis
    Tamirisa, Nina
    Lin, Heather
    Shen, Yu
    Shaitelman, Simona F.
    Karuturi, Meghan S.
    Giordano, Sharon H.
    Babiera, Gildy V.
    Bedrosian, Isabelle
    CANCER, 2021, 127 (13) : 2196 - 2203
  • [45] Testing Endocrine Response for Managing Primary Estrogen Receptor-Positive Breast Cancer
    Dowsett, Mitch
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2520 - +
  • [46] Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Liu, Bo
    Ross, Dara S.
    Schram, Alison M.
    Razavi, Pedram
    Lagana, Stephen M.
    Zhang, Yanming
    Scaltriti, Maurizio
    Bromberg, Jacqueline F.
    Ladanyi, Marc
    Hyman, David M.
    Drilon, Alexander
    Zahir, Ahmet
    Benayed, Ryma
    Hechtman, Jaclyn F.
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2020, 80 (16)
  • [47] Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
    Engelking, Marta
    Marmor, Schelomo
    Burjak, Mohamad
    Hinojos, Madeleine
    Lloyd, Whitney
    Switalla, Kayla M.
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 187 - 195
  • [48] Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer
    Massarweh, Suleiman
    Moss, Jessica
    Wang, Chi
    Romond, Edward
    Slone, Stacey
    Weiss, Heidi
    Karabakhtsian, Rouzan G.
    Napier, Dana
    Black, Esther P.
    FUTURE ONCOLOGY, 2014, 10 (15) : 2435 - 2448
  • [49] Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer A Systematic Review and Meta-analysis
    Spring, Laura M.
    Gupta, Arjun
    Reynolds, Kerry L.
    Gadd, Michele A.
    Ellisen, Leif W.
    Isakoff, Steven J.
    Moy, Beverly
    Bardia, Aditya
    JAMA ONCOLOGY, 2016, 2 (11) : 1477 - 1486
  • [50] Impact of clinicopathological factors on extended endocrine therapy decision making in estrogen receptor-positive breast cancer
    Chen, Weilin
    Wu, Jiayi
    Zhu, Yifei
    Huang, Jiahui
    Chen, Xiaosong
    Huang, Ou
    He, Jianrong
    Li, Yafen
    Chen, Weiguo
    Shen, Kunwei
    Zhu, Li
    FRONTIERS IN ONCOLOGY, 2023, 12